Constance Delaby

3.5k total citations · 1 hit paper
66 papers, 1.9k citations indexed

About

Constance Delaby is a scholar working on Physiology, Molecular Biology and Hematology. According to data from OpenAlex, Constance Delaby has authored 66 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Physiology, 18 papers in Molecular Biology and 18 papers in Hematology. Recurrent topics in Constance Delaby's work include Alzheimer's disease research and treatments (22 papers), Iron Metabolism and Disorders (18 papers) and Dementia and Cognitive Impairment Research (16 papers). Constance Delaby is often cited by papers focused on Alzheimer's disease research and treatments (22 papers), Iron Metabolism and Disorders (18 papers) and Dementia and Cognitive Impairment Research (16 papers). Constance Delaby collaborates with scholars based in France, Spain and United States. Constance Delaby's co-authors include François Canonne‐Hergaux, Carole Beaumont, Sylvain Lehmann, Nathalie Pilard, Christophe Hirtz, Ana Sofia Gonçalves, Hervé Puy, Audrey Gabelle, Jérôme Vialaret and J Ducos and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Constance Delaby

63 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Challenges in the practical implementation of blood biomarkers for Alzheimer’s disease

2024 34 citations Michael Schöll, Inge M.W. Verberk et al. The Lancet Healthy Longevity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Constance Delaby France	24	691	591	546	533	397	66	1.9k
Fuad Abdulla United States	26	436 0.6×	925 1.6×	1.1k 1.9×	654 1.2×	83 0.2×	69	2.4k
Sandra Mariel Martin Argentina	12	207 0.3×	292 0.5×	264 0.5×	65 0.1×	311 0.8×	30	1.2k
Rosario Garrido United States	16	294 0.4×	173 0.3×	409 0.7×	91 0.2×	115 0.3×	27	1.2k
Ying He China	26	111 0.2×	382 0.6×	475 0.9×	157 0.3×	40 0.1×	89	1.6k
B.K. Thelma India	32	71 0.1×	371 0.6×	768 1.4×	107 0.2×	65 0.2×	139	2.8k
Jean‐François Benoist France	26	86 0.1×	380 0.6×	1.0k 1.9×	54 0.1×	103 0.3×	95	2.3k
Sébastien Fuchs United States	31	63 0.1×	236 0.4×	1.2k 2.2×	265 0.5×	149 0.4×	71	2.9k
Masaki Takao Japan	28	66 0.1×	600 1.0×	1.4k 2.5×	147 0.3×	149 0.4×	160	3.1k
Karl Morten United Kingdom	29	63 0.1×	493 0.8×	1.9k 3.5×	87 0.2×	65 0.2×	83	3.0k
Joseph F. Ross United States	25	381 0.6×	289 0.5×	214 0.4×	233 0.4×	138 0.3×	60	2.0k

Countries citing papers authored by Constance Delaby

Since Specialization

Citations

This map shows the geographic impact of Constance Delaby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constance Delaby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constance Delaby more than expected).

Fields of papers citing papers by Constance Delaby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Constance Delaby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constance Delaby. The network helps show where Constance Delaby may publish in the future.

Co-authorship network of co-authors of Constance Delaby

This figure shows the co-authorship network connecting the top 25 collaborators of Constance Delaby. A scholar is included among the top collaborators of Constance Delaby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Constance Delaby. Constance Delaby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Delaby, Constance, Elisa De La Cruz, Jens Kühle, et al.. (2025). Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral Sclerosis. Neurology. 104(6). e213400–e213400. 6 indexed citations

Schraen‐Maschke, Susanna, Isabelle Quadrio, Olivier Bousiges, et al.. (2024). A French multicenter analytical evaluation of the automated Lumipulse G sNfL blood assay (Fujirebio®) and its comparison to four other immunoassays for serum neurofilament light chain assessment in clinical settings. Clinica Chimica Acta. 565. 120007–120007. 2 indexed citations

Lehmann, Sylvain, Susanna Schraen‐Maschke, Jean‐Sébastien Vidal, et al.. (2024). Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment. Journal of Neurology Neurosurgery & Psychiatry. 95(11). 1046–1053. 20 indexed citations

Delaby, Constance & Sylvain Lehmann. (2024). Vers un diagnostic biologique sanguin de la maladie d’Alzheimer ?. médecine/sciences. 40(4). 351–360.

Lehmann, Sylvain, Susanna Schraen‐Maschke, Luc Buée, et al.. (2024). Clarifying the association of CSF Aβ, tau, BACE1, and neurogranin with AT(N) stages in Alzheimer disease. Molecular Neurodegeneration. 19(1). 66–66. 8 indexed citations

Schöll, Michael, Inge M.W. Verberk, Marta del Campo, et al.. (2024). Challenges in the practical implementation of blood biomarkers for Alzheimer’s disease. The Lancet Healthy Longevity. 5(10). 100630–100630. 34 indexed citations breakdown →

Blum, David, Hélène Behal, Jean‐Sébastien Vidal, et al.. (2024). Association of caffeine consumption with cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer's disease: A BALTAZAR cohort study. Alzheimer s & Dementia. 20(10). 6948–6959. 5 indexed citations

Lehmann, Sylvain, Susanna Schraen‐Maschke, Jean‐Sébastien Vidal, et al.. (2023). Blood Neurofilament Levels Predict Cognitive Decline across the Alzheimer’s Disease Continuum. International Journal of Molecular Sciences. 24(24). 17361–17361. 12 indexed citations

Lehmann, Sylvain, Susanna Schraen‐Maschke, Jean‐Sébastien Vidal, et al.. (2023). Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function. Journal of Neurology Neurosurgery & Psychiatry. 94(6). 411–419. 32 indexed citations

10.

Delaby, Constance, Elisa De La Cruz, Jens Kühle, et al.. (2023). Serum neurofilament light chain cut‐off definition for clinical diagnosis and prognosis of amyotrophic lateral sclerosis. European Journal of Neurology. 30(7). 1919–1927. 10 indexed citations

11.

Lehmann, Sylvain, Susanna Schraen‐Maschke, Jean‐Sébastien Vidal, et al.. (2023). Head-to-Head Comparison of Two Plasma Phospho-tau Assays in Predicting Conversion of Mild Cognitive Impairment to Dementia. Clinical Chemistry. 69(9). 1072–1083. 4 indexed citations

12.

Lehmann, Sylvain, et al.. (2022). Comparison of cerebrospinal fluid tau, ptau(181), synuclein, and 14-3-3 for the detection of Creutzfeldt–Jakob disease in clinical practice. Journal of Neural Transmission. 129(2). 133–139. 3 indexed citations

13.

Delaby, Constance, Daniel Alcolea, Christophe Hirtz, et al.. (2022). Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles. Journal of Neural Transmission. 129(2). 231–237. 16 indexed citations

14.

Hirtz, Christophe, et al.. (2021). Tau protein in cerebrospinal fluid: a novel biomarker of the time of death?. International Journal of Legal Medicine. 135(5). 2081–2089. 12 indexed citations

15.

Lehmann, Sylvain, Julien Dumurgier, Xavier Ayrignac, et al.. (2020). Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals. Alzheimer s Research & Therapy. 12(1). 123–123. 40 indexed citations

16.

Vialaret, Jérôme, et al.. (2018). Nano-flow vs standard-flow: Which is the more suitable LC/MS method for quantifying hepcidin-25 in human serum in routine clinical settings?. Journal of Chromatography B. 1086. 110–117. 7 indexed citations

17.

Lehmann, Sylvain, Constance Delaby, J. Touchon, Christophe Hirtz, & Audrey Gabelle. (2013). Biomarkers of Alzheimer's disease: The present and the future. Revue Neurologique. 169(10). 719–723. 16 indexed citations

18.

Delaby, Constance, et al.. (2012). Correction: Subcellular Localization of Iron and Heme Metabolism Related Proteins at Early Stages of Erythrophagocytosis. PLoS ONE. 7(12). 11 indexed citations

19.

Delaby, Constance, Christiane Rondeau, Cécile Pouzet, et al.. (2012). Subcellular Localization of Iron and Heme Metabolism Related Proteins at Early Stages of Erythrophagocytosis. PLoS ONE. 7(7). e42199–e42199. 55 indexed citations

20.

Delaby, Constance, Nathalie Pilard, Ana Sofia Gonçalves, Carole Beaumont, & François Canonne‐Hergaux. (2005). Presence of the iron exporter ferroportin at the plasma membrane of macrophages is enhanced by iron loading and down-regulated by hepcidin. Blood. 106(12). 3979–3984. 230 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact